Events
![](https://www.vivet-therapeutics.com/wp-content/uploads/2021/10/european.png)
VIVET THERAPEUTICS ANNOUNCES 2 ORAL PRESENTATIONS AND 4 ABSTRACTS AT 2021 ESGCT ANNUAL MEETING
VIVET THERAPEUTICS ANNOUNCES 2 ORAL PRESENTATIONS AND 4 ABSTRACTS AT 2021 ESGCT ANNUAL MEETING
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/03/Rectangle-17.jpg)
Vivet CDO, Anne Douar, presenting during SFTCG webinar on Gene Therapy for Wilson Disease
Vivet CDO, Anne Douar, will be presenting
![](https://www.vivet-therapeutics.com/wp-content/uploads/2021/05/Rectangle.png)
Vivet Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 ASGCT Annual Meeting
Vivet Therapeutics Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 American Society Of Gene And Cell Therapy Annual Meeting
![](https://www.vivet-therapeutics.com/wp-content/uploads/2021/04/Rectangle-35.png)
VIVET ATTENDING ARM 2021 CELL & GENE MEETING ON THE MED
Jean-Philippe Combal, Vivet CEO, will be attending a panel during the Cell & Gene Meeting on the Med – virtual, organized by the ARM on April 6-9, 2021. The panel, “TRENDS AND CHALLENGES IN GENE THERAPY IN EUROPE”, will be held on April 7, 3-4pm CET.
![](https://www.vivet-therapeutics.com/wp-content/uploads/2020/11/jefferies.png)
VIVET ATTENDING JEFFERIES 2020 VIRTUAL LONDON HEALTHCARE CONFERENCE
Jean-Philippe Combal, Vivet Therapeutics’ CEO, and Thomas Daniel, BD Director, will be hosting 1×1 meetings during Jefferies 2020 London Healthcare Conference on November 17-19.
![](https://www.vivet-therapeutics.com/wp-content/uploads/2020/10/gene-therapy.png)
VIVET PRESENTING DURING 2020 4th ANNUAL GENE THERAPY FOR RARE DISORDERS EUROPE CONFERENCE
Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/Chardan-Capital.png)
VIVET ATTENDING CHARDAN’S 4th ANNUAL GENETIC MEDICINES CONFERENCE
VIVET ATTENDING CHARDAN’S 4th ANNUAL GENETIC MEDICINES CONFERENCE
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/HTID2020-768x363.png)
VIVET IS PARTICIPATING TO THE HEALTHTECH INNOVATION DAYS 2020 (HTID) IN PARIS
VIVET ATTENDING THE HEALTHTECH INNOVATION DAYS (HTID) IN PARIS
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/DNA-490376259-768x512.jpg)
VIVET IS PARTICIPATING TO THE PAEDIATRIC CHOLESTASIS WORKSHOP – PART ONE 2020
Bernard Benichou Vivet Therapeutics’ CMO will be participating to a panel and Jean-Philippe Combal, CEO and Sonia Valero, Head of Clinical Operations…
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/ASGCT-2020-768x256.png)
Vivet Therapeutics Announces 2 Abstracts Presentation At 2020 ASGCT Annual Meeting
Vivet Therapeutics, a privately held gene therapy biotech company